-Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 This Phase III clinical trial is a randomized, double-blind, ...

You may have thought pimples were in your past, but one day you look in the mirror and discover that a zit has sprouted on your chin. Or maybe a crop of unsightly reddish bumps has popped up on your ...

Millions of people deal with acne, but those who suffer from cystic acne know how difficult it is to treat compared to ordinary pimples. Cystic acne is a severe form of acne that results in large, pus ...

Witch hazel has anti-inflammatory and astringent properties, which make it useful for treating acne. It can soothe the skin and remove oil and sebum from the surface. Witch hazel can soothe irritated ...

No matter your age, having persistent acne can feel disheartening. You may have tried countless treatment options, ranging from dietary changes to medical treatment, but nothing has worked. Some ...

Everyone’s acne journey is different, but we somehow all end up using the same types of products. You likely possess an army of acne-fighting cleansers, treatment face masks, and, hopefully, loads of ...

HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat ...